| Title |
A Phase II Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined with Albumin-Bound Paclitaxel in Advanced Cervical Cancer after First-Line Standard Chemotherapy |
| Description |
To evaluate the safety, tolerability, and clinical efficacy of HLX10 combined with albumin-bound paclitaxel in patients with advanced CC who have failed first-line standard chemotherapy. Planned screening 286 subject and enrolled 143 subject. |
| Organism |
Homo sapiens |
| Data Type |
Biomarker Data |
| Data Accessibility |
Controlled-access |
| BioProject |
PRJCA013700 |
| Release Date |
2024-12-31 |
| Submitter |
Jusheng An (anmanman_0@126.com) |
| Organization |
Cancer Hospital, Chinese Academy of Medical Sciences |
| Submission Date |
2022-12-06 |